Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Year
93 results
-
Consultation Paper 10 – General Use Items utilisation, expenditure and integrity
This circular is to advise stakeholders of the publication of a high level summary and individual submissions. -
Advice on the benefit reductions to Cardiac Implantable Electronic Devices
The document contains advice on the third and final reduction of benefits for Cardiac Implantable Electronic Devices (CIED) effective 1 July 2025. -
National Nursing Workforce Strategy Advisory Group communique – 17 February 2025
The eighth meeting of the National Nursing Workforce Strategy Advisory Group (SAG) was held on 17 February 2025. -
Prescribed List of Medical Devices and Human Tissue Products
This page lists the medical devices and human tissue products private health insurers must pay benefits for to the patients who have appropriate insurance policies. The latest version of the Prescribed List is effective from 1 July 2025. -
Stakeholder feedback summary – Consultation Paper 9 – CIED and the cost of technical support services
This document provides a high-level summary of stakeholder feedback received in response to Consultation Paper 9 – CIED and the cost of technical support services. -
National Nursing Workforce Strategy Advisory Group communique – 9 December 2024
The seventh meeting of the National Nursing Workforce Strategy Advisory Group (SAG) was held on 9 December 2024. -
National Nursing Workforce Strategy Steering Committee communique – 11 December 2024
The sixth meeting of the National Nursing Workforce Strategy Steering Committee (SSC) was held on 11 December 2024. -
National Nursing Workforce Strategy – Round two consultation summary report
This report contains findings from round two of stakeholder consultation on the draft National Nursing Workforce Strategy. It offers a comprehensive summary of the consultation process and the feedback received from stakeholders. -
Prescribed List post-listing review framework
We have developed a Prescribed List Post-listing Review Framework that is used to guide the post-listing review process as part of the Prescribed List Reforms. -
Interim Evaluation #1 of the Prescribed List Reforms
The interim evaluation report covers the period from May 2021 to June 2024 and reports on whether the reforms being implemented and achieving the expected outcomes. -
Reforms to the Prescribed List Part B – Analysis of stakeholder feedback
This report is to provide an analysis of stakeholder feedback received. -
Baseline evaluation of the Prostheses List reforms – Final report
This evaluation focuses on the Prostheses List reforms, which are running from 1 July 2021 to 30 June 2025. Evaluation of these reforms will determine whether the reform program is being implemented as intended. -
Prescribed List billing codes – Removal of medicine and medicine accessories – 1 November 2024
This list includes details of the 26 billing codes for medicines and related accessories scheduled to be removed from Part D of the Prescribed List effective 1 November 2024. -
National Nursing Workforce Strategy Advisory Group communique – 26 September 2024
The sixth meeting of the National Nursing Workforce Strategy Advisory Group (SAG) was held on 26 September 2024. -
Consultation Paper 7 – Proposed measures for compliance, assurance and information sharing
This report provides an analysis of stakeholder feedback received in response to the Consultation Paper on the proposed Compliance, Assurance and Information sharing measures for the Prescribed List (PL). -
Consultation Paper 8a – Gifts, benefits and discounts reporting requirement
This report provides an analysis of stakeholder feedback received in response to the consultation paper on the proposed measure: Prescribed List (PL) gifts, benefits and discounts reporting requirements. -
Consultation Paper 8b – Alignment of amount charged for supply of a device with corresponding PL benefit
This report provides an analysis of stakeholder feedback received in response to the consultation paper on the proposed measure: alignment of amount charged for supply of a device with corresponding PL benefit. -
National Nursing Workforce Strategy – building the evidence base
These reports provide a comprehensive summary of research and stakeholder consultation findings. They form the evidence base used to guide the development of the National Nursing Workforce Strategy. -
National Nursing Workforce Strategy – Volume 2 Research Report
This report brings together a large collection of data from Australia and around the world to present a comprehensive catalogue of initiatives, programs and ideas that could be considered in development of the National Nursing Workforce Strategy. -
National Nursing Workforce Strategy – Volume 1 Research Report
This report provides a comprehensive summary of the consultation findings, across all formats and methodologies. It provides a robust, detailed and evidence‑based summary of the current state of nursing in Australia, as reported by nurses and stakeholders. -
National Nursing Workforce Strategy – Summary of Environment Scans
This summary document provides an overview of findings from individual environmental scans of 14 countries, including Australia and 5 international organisations. -
16:21
Prescribed List – practical tips on submitting applications
This webinar recording provides practical tips on submitting applications. -
National Nursing Workforce Strategy Advisory Group communique – 1 August 2024
The fifth meeting of the National Nursing Workforce Strategy Advisory Group (SAG) was held on 1 August 2024. -
National Nursing Workforce Strategy Steering Committee communique – 16 July 2024
The fifth meeting of the National Nursing Workforce Strategy Steering Committee (SSC) was held on 16 July 2024. -
Prostheses List Post-Listing review – Consultants report
This report is a review of surgical guides and biomodels currently listed on the Prostheses List.